Despite broader economic challenges, the biotech industry thrives due to consistent innovation and steady demand. An aging population and the need for high-quality treatments for rare and common diseases back the optimism surrounding the industry.
Therefore, it might be wise to invest in fundamentally strong biotech stocks, such as Organogenesis Holdings Inc. (ORGO), Genmab A/S (GMAB), and Incyte Corporation (INCY).
